Dr. Katerina Erokhina, D.O

NPI: 1437404571
Total Payments
$3,754
2024 Payments
$373.93
Companies
40
Transactions
120
Medicare Patients
5,435
Medicare Billing
$348,523

Payment Breakdown by Category

Food & Beverage$3,569 (95.1%)
Education$184.94 (4.9%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $3,569 117 95.1%
Education $184.94 3 4.9%

Top Paying Companies

Company Total Records Latest Year
Genentech USA, Inc. $523.68 14 $0 (2024)
AstraZeneca Pharmaceuticals LP $371.07 9 $0 (2022)
Daiichi Sankyo Inc. $285.37 4 $0 (2022)
Amgen Inc. $233.03 12 $0 (2022)
Celgene Corporation $205.89 10 $0 (2023)
Millennium Pharmaceuticals, Inc. $198.60 2 $0 (2017)
Novartis Pharmaceuticals Corporation $146.20 8 $0 (2022)
Adaptive Biotechnologies Corporation $144.72 1 $0 (2024)
Merck Sharp & Dohme Corporation $142.88 9 $0 (2020)
SERVIER PHARMACEUTICALS LLC $138.48 3 $0 (2022)

Payment History by Year

Year Amount Transactions Top Company
2024 $373.93 4 Genentech USA, Inc. ($148.75)
2023 $366.46 8 Genentech USA, Inc. ($149.60)
2022 $290.32 14 Celgene Corporation ($79.99)
2021 $318.68 7 Servier Pharmaceuticals LLC ($125.85)
2020 $193.44 5 Daiichi Sankyo Inc. ($125.00)
2019 $907.49 35 AstraZeneca Pharmaceuticals LP ($156.07)
2018 $167.75 12 Amgen Inc. ($53.63)
2017 $1,136 35 Millennium Pharmaceuticals, Inc. ($198.60)

All Payment Transactions

120 individual payment records from CMS Open Payments — Page 1 of 5

Date Company Product Nature Form Amount Type
11/14/2024 Adaptive Biotechnologies Corporation clonoSEQ (Device) Food and Beverage Cash or cash equivalent $144.72 General
Category: ONCOLOGY
05/18/2024 Genmab U.S., Inc. Epkinly (Drug) Food and Beverage In-kind items and services $65.79 General
Category: Oncology
05/10/2024 Tempus AI, Inc XT CDX (Device) Food and Beverage In-kind items and services $14.67 General
Category: NONE
05/01/2024 Genentech USA, Inc. Lunsumio (Biological), Columvi Food and Beverage In-kind items and services $148.75 General
Category: BioOncology
11/30/2023 Genentech USA, Inc. Polivy (Biological), Columvi Food and Beverage In-kind items and services $129.76 General
Category: BioOncology
08/21/2023 Celgene Corporation REBLOZYL (Biological) Food and Beverage Cash or cash equivalent $17.54 General
Category: Hematology
06/19/2023 AVEO Pharmaceuticals, Inc. FOTIVDA (Drug) Food and Beverage In-kind items and services $18.64 General
Category: Oncology
06/08/2023 SOBI, INC Doptelet (Drug) Food and Beverage In-kind items and services $113.87 General
Category: HEMATOLOGY/ONCOLOGY
05/17/2023 Genentech USA, Inc. Gazyva (Biological), Venclexta Food and Beverage In-kind items and services $19.84 General
Category: BioOncology
05/10/2023 Puma Biotechnology, Inc. Food and Beverage In-kind items and services $18.79 General
04/11/2023 Celgene Corporation OPDUALAG (Drug) Food and Beverage Cash or cash equivalent $17.40 General
Category: Oncology
04/10/2023 Celgene Corporation OPDUALAG (Drug) Food and Beverage Cash or cash equivalent $30.62 General
Category: Oncology
09/20/2022 Celgene Corporation REBLOZYL (Biological) Food and Beverage Cash or cash equivalent $23.74 General
Category: Hematology
09/07/2022 Gilead Sciences, Inc. Trodelvy (Drug) Food and Beverage In-kind items and services $24.85 General
Category: ONC
08/25/2022 Daiichi Sankyo Inc. ENHERTU (Drug) Food and Beverage In-kind items and services $19.42 General
Category: ONCOLOGY
08/16/2022 Astellas Pharma US Inc PADCEV (Drug) Food and Beverage In-kind items and services $21.75 General
Category: Oncology
08/10/2022 Foundation Medicine, Inc. FOUNDATIONONE (Device), FOUNDATIONONE HEME, FOUNDATIONONE CDX Food and Beverage In-kind items and services $18.33 General
Category: ONCOLOGY
08/05/2022 Cepheid Food and Beverage In-kind items and services $18.42 General
06/06/2022 AstraZeneca Pharmaceuticals LP ENHERTU (Biological) Food and Beverage In-kind items and services $14.15 General
Category: Oncology
05/31/2022 AstraZeneca Pharmaceuticals LP IMFINZI (Biological) Food and Beverage In-kind items and services $19.44 General
Category: Oncology
05/17/2022 Celgene Corporation REBLOZYL (Biological) Food and Beverage Cash or cash equivalent $30.61 General
Category: Hematology
05/10/2022 Daiichi Sankyo Inc. ENHERTU (Drug) Food and Beverage In-kind items and services $23.00 General
Category: ONCOLOGY
03/29/2022 Novartis Pharmaceuticals Corporation KISQALI (Drug), FEMARA Food and Beverage In-kind items and services $17.04 General
Category: ONCOLOGY
03/22/2022 Celgene Corporation Pomalyst (Drug) Food and Beverage Cash or cash equivalent $25.64 General
Category: Hematology
03/15/2022 Amgen Inc. LUMAKRAS (Drug) Food and Beverage In-kind items and services $21.30 General
Category: Oncology

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 6 330 379 $82,647 $33,106
2022 5 320 579 $226,736 $56,252
2021 5 271 464 $141,106 $45,100
2020 47 4,514 48,001 $1.4M $214,065
Total Patients
5,435
Total Services
49,423
Medicare Billing
$348,523
Procedure Codes
66

All Medicare Procedures & Services

66 procedure records from CMS Medicare Utilization — Page 1 of 3

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 82 109 $23,342 $11,167 47.8%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 100 112 $16,912 $7,873 46.6%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 80 80 $19,805 $7,399 37.4%
99215 Established patient office or other outpatient visit, 40-54 minutes Facility 2023 20 29 $13,862 $3,262 23.5%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2023 14 14 $4,619 $1,560 33.8%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 22 23 $2,254 $1,180 52.3%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2023 12 12 $1,853 $664.76 35.9%
99215 Established patient office or other outpatient visit, 40-54 minutes Facility 2022 127 296 $131,720 $32,424 24.6%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2022 105 191 $60,165 $14,207 23.6%
99205 New patient office or other outpatient visit, 60-74 minutes Facility 2022 43 43 $23,435 $5,884 25.1%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 20 20 $4,920 $2,330 47.4%
99213 Established patient office or other outpatient visit, 20-29 minutes Facility 2022 25 29 $6,496 $1,408 21.7%
99215 Established patient outpatient visit, total time 40-54 minutes Facility 2021 107 240 $89,629 $27,206 30.4%
99214 Established patient outpatient visit, total time 30-39 minutes Facility 2021 107 167 $36,973 $12,419 33.6%
99204 New patient outpatient visit, total time 45-59 minutes Facility 2021 26 26 $6,706 $2,496 37.2%
99205 New patient outpatient visit, total time 60-74 minutes Facility 2021 16 16 $5,962 $2,167 36.4%
99213 Established patient outpatient visit, total time 20-29 minutes Facility 2021 15 15 $1,836 $811.68 44.2%
J0897 Injection, denosumab, 1 mg Office 2020 33 3,060 $159,120 $45,654 28.7%
Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) Office 2020 36 29,580 $147,900 $24,323 16.4%
J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units Office 2020 37 3,050 $122,000 $23,964 19.6%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 147 317 $70,374 $23,568 33.5%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 232 375 $65,625 $18,001 27.4%
96413 Infusion of chemotherapy into a vein up to 1 hour Office 2020 32 123 $55,596 $12,301 22.1%
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test Office 2020 326 716 $65,156 $5,442 8.4%
99214 Established patient office or other outpatient, visit typically 25 minutes Facility 2020 36 73 $11,242 $4,634 41.2%

About Dr. Katerina Erokhina, D.O

Dr. Katerina Erokhina, D.O is a Internal Medicine healthcare provider based in Vancouver, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/16/2012. The National Provider Identifier (NPI) number assigned to this provider is 1437404571.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Katerina Erokhina, D.O has received a total of $3,754 in payments from pharmaceutical and medical device companies, with $373.93 received in 2024. These payments were reported across 120 transactions from 40 companies. The most common payment nature is "Food and Beverage" ($3,569).

As a Medicare-enrolled provider, Erokhina has provided services to 5,435 Medicare beneficiaries, totaling 49,423 services with total Medicare billing of $348,523. Data is available for 4 years (2020–2023), covering 66 distinct procedure/service records.

Practice Information

  • Specialty Internal Medicine
  • Other Specialties Hematology, Hematology & Oncology
  • Location Vancouver, WA
  • Active Since 07/16/2012
  • Last Updated 07/16/2020
  • Taxonomy Code 207R00000X
  • Entity Type Individual
  • NPI Number 1437404571

Products in Payments

  • NINLARO (Drug) $211.18
  • TAGRISSO (Drug) $206.59
  • Lunsumio (Biological) $148.75
  • clonoSEQ (Device) $144.72
  • TIBSOVO (Drug) $138.48
  • Avastin (Biological) $135.42
  • Imbruvica (Drug) $130.37
  • Polivy (Biological) $129.76
  • KEYTRUDA (Biological) $127.75
  • Doptelet (Drug) $125.18
  • Enhertu (Drug) $125.00
  • INJECTAFER (Drug) $117.95
  • THERASPHERE-BIO (Device) $114.24
  • FARYDAK (Drug) $106.54
  • CYRAMZA (Drug) $97.33
  • LYNPARZA (Drug) $88.19
  • VELCADE (Drug) $85.20
  • REBLOZYL (Biological) $71.89
  • Neulasta (Biological) $70.89
  • Epkinly (Drug) $65.79

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Internal Medicine Doctors in Vancouver